Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q30470260)
Watch
English
Lamotrigine in childhood epilepsies
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
review article
1 reference
stated in
Europe PubMed Central
title
Lamotrigine in childhood epilepsies
(English)
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
main subject
lamotrigine
1 reference
based on heuristic
inferred from title
author name string
F E Dreifuss
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
publication date
1 March 1997
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
published in
Seminars in pediatric neurology
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
volume
4
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
issue
1
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
page(s)
19-23
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
cites work
The development of antiepileptic drugs for children. Report from the NIH workshop, Bethesda, Maryland, February 17-18, 1994
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Sodium valproate acutely inhibits lamotrigine metabolism
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Controlled trial of lamotrigine (Lamictal) for refractory partial seizures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A randomised double-blind placebo-controlled crossover add-on trial of lamotrigine in patients with treatment-resistant partial seizures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Placebo-controlled study of the efficacy and safety of lamotrigine in patients with partial seizures. U.S. Lamotrigine Protocol 0.5 Clinical Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine therapy for partial seizures: a multicenter, placebo-controlled, double-blind, cross-over trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Overview of the Clinical Efficacy of Lamotrigine
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind, placebo controlled, crossover study of lamotrigine in treatment resistant partial seizures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. UK Lamotrigine/Carbamazepine Monotherapy Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine as an add-on drug in typical absence seizures
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine: clinical experience in 93 patients with epilepsy.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine in treatment of 120 children with epilepsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine for the treatment of epilepsy in childhood
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine in primary generalised epilepsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine in resistant childhood epilepsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Vigabatrin and lamotrigine in refractory epilepsy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Epilepsy with myoclonic absences
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Management issues in severe childhood epilepsies
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine in infantile spasms
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intractable epilepsy in children. The efficacy of lamotrigine treatment, including non-seizure-related benefits.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Lamotrigine in Rett syndrome
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1016%2FS1071-9091%2897%2980005-8
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1016/S1071-9091(97)80005-8
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
PubMed ID
9097363
1 reference
stated in
Europe PubMed Central
PubMed ID
9097363
retrieved
21 June 2017
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit